Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Oct 26, 2017
    Coalition Concerned Tax Deal Could Include Marketing Cost Deduction
  • Oct 26, 2017
    Survey Finds Payers Prefer Digital Data
  • Oct 26, 2017
    Two Michigan Counties Sue Opioid Manufacturers Over Marketing
  • Oct 26, 2017
    FTC Sends Nearly $10 Million To Consumers Charged for Health Formulas “Free Trials”
  • Oct 26, 2017
    Material Review Committees Must be Set Up Correctly
  • Oct 26, 2017
    Nevada Sales Rep Registration Starts
  • Oct 26, 2017
    FDA-Flawless Beauty Enter Consent Decree
  • Oct 25, 2017
    Study Finds Listing Serious and Frequent Risks May ‘Dampen’ Consumer Judgments on Overall Severity
  • Oct 18, 2017
    Maker of Customized Dietary Supplements Shuttered by Consent Decree Due to Alleged cGMP Violations
  • Oct 12, 2017
    Pharmacy’s Alleged Drug Recycling Scheme Leads to Conspiracy Guilty Pleas, False Claims Settlement
  • More

Good Clinical Practice

  • Feb 23, 2018
    FDA Issues Final Rule on Acceptance of Device Trial Data
  • Feb 20, 2018
    AllTrials Calls for FDA Enforcement of Trial Result Reporting; Starts Flagging Offenders
  • Feb 17, 2018
    FDA Plans Meeting in August on Pediatric Device Development
  • Feb 16, 2018
    FDA To Host Workshop on Rare Disease Trial Designs
  • Feb 12, 2018
    Miss. Senate Passes Bill Clarifying Research Involving Minors
  • Feb 12, 2018
    Guidelines for Use of PROs in Trials Issued
  • Feb 9, 2018
    TransCelerate Targets HCPs in Campaign To Increase Clinical Trial Participation
  • Feb 9, 2018
    39 Patient Advocacy Groups Oppose Present Federal Right-to-Try Legislation
  • Feb 7, 2018
    India-Based CRO Sues FDA for $50 Million in Damages, Alleging Injury Resulting from Enforcement Action
  • Feb 2, 2018
    Better Patient Risk Models Could Aid Trials
  • More

U.S. Food Labeling

  • Aug 31,2012
    FTC Refunds Consumers from 2010 Settlement
  • Aug 31,2012
    Bill Seeks Menu Labeling Breaks for Pizza Chains
  • Aug 31,2012
    Product Recalls
  • Aug 12,2012
    Frozen Pizza Company Gets FDA Warning Letter
  • Aug 11,2012
    Pfizer Agrees To Remove Breast and Colon Health Claims from Centrum Multivitamin Supplements
  • Aug 7,2012
    California's GE Labeling Ballot Initiative Could Be a Game Changer
  • Aug 4,2012
    U.S. Appeals Court Rejects 2010 Cereal Settlement
  • Aug 3,2012
    Health Groups Ask Sebelius for Surgeon General Report on Harmful Effects of Sugary Drinks
  • Aug 2,2012
    WTO Appellate Body Rules Against USDA's Country Of Origin Labeling for Beef and Pork
  • Jul 31,2012
    AMA Policy Position on Labeling of GE Foods in Line with FDA's 'Science-based Approach'
  • More

FDA Regulation & Enforcement

  • Oct 29, 2020
    FDA Wants Feedback on Labeling ‘Nontraditional’ Sugars
  • Oct 23, 2020
    DOJ Reaches Global Settlement with Purdue Pharma
  • Oct 20, 2020
    Former Supplement Company Executives Sentenced to Prison Terms for Roles in Fraudulent Marketing
  • Oct 16, 2020
    Details of Mallinckrodt’s Global Opioid Settlement Released
  • Oct 15, 2020
    Gilead To Pay $97 Million To Resolve Kickback Allegations over Foundation Copays
  • Oct 15, 2020
    Former Compliance Officer’s Qui Tam Suit Leads to $18 Million Settlement with Merit Medical Systems
  • Oct 15, 2020
    FDA Asks for Input on Labeling Cell-based Seafood
  • Oct 8, 2020
    OIG: Drug Maker’s Cost-Sharing Plan for Medicare Beneficiaries Would Violate Anti-Kickback Statute
  • Oct 4, 2020
    OPDP Issues Two More Warning Letters
  • Oct 1, 2020
    HHS Finalizes Rule Permitting Importation of Rx Drugs from Canada; ‘Significant’ Savings Foreseen
  • More

Medical Devices

  • May 16, 2015
    FDA Promotes Adaptive Designs for Device Trials
  • May 14, 2015
    Siemens Medical Solutions USA Resolves Dispute Over Federal Procurement Discounts for $5.9 Million
  • May 14, 2015
    FDA Outlines Use of Patient Preference Information in PMAs, HDEs, De Novo Requests
  • May 6, 2015
    UDI Information Now Available to the Public Through Beta Version of AccessGUDID Portal
  • Apr 30, 2015
    CDRH Invites Participation in Pilot Program To Collect Home-Use Device Labeling Online
  • Apr 30, 2015
    Consent Decree Stops Production, Distribution of Medtronic Implantable Infusion Pump Device
  • Apr 23, 2015
    10th Circuit: Claims Stemming from Off-Label Use of PMA Device Preempted by Federal Law
  • Apr 17, 2015
    FDA Finalizes Guidance on Balancing Premarket, Postmarket Data for PMA Devices
  • Apr 15, 2015
    FDA Launches Program for Expedited Access to Devices Addressing Unmet Medical Needs
  • Apr 8, 2015
    CDRH Seeks To Visit Device Industry, Academic, Health Care Facilities for Center Staff Training
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.